{"content":"<li class=\"n-box-item date-title\" data-end=\"1459396799\" data-start=\"1459310400\" data-txt=\"Sunday, December 22, 2019\">Wednesday, March 30, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3170534\" data-ts=\"1459379143\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIO\" target=\"_blank\">CIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170534-city-office-reit-prices-7m-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">City Office REIT prices 7M-share offering</a></h4><ul>   <li>City Office REIT (<a href=\"https://seekingalpha.com/symbol/CIO\" title=\"City Office REIT, Inc.\">CIO</a> <font color=\"red\">-4.5%</font>) is <font color=\"green\">up 1.1%</font> after hours after pricing a public offering of stock.</li>    <li>The company priced an underwritten offering of 7M shares at $11.40/share. The stock closed at $11.47 today and is quoting at $11.50 in late trading.</li>    <li>Total gross proceeds came to $79.8M, which the company will use to repay debt and for general purposes that could include acquisitions and reserves for capex.</li>    <li>Underwriters have a 30-day greenshoe option for up to 1.05M more shares. The offering is expected to close April 5.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170534\" data-linked=\"City Office REIT prices 7M-share offering\" data-tweet=\"$CIO - City Office REIT prices 7M-share offering https://seekingalpha.com/news/3170534-city-office-reit-prices-7m-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3170534-city-office-reit-prices-7m-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170511\" data-ts=\"1459374287\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPM\" target=\"_blank\">WPM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170511-silver-wheatonminus-6-on-500m-bought-deal-financing-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Silver Wheaton -6% on $500M bought-deal financing plan</a></h4><ul>     <li>Silver Wheaton (SLW) <font color=\"red\">-5.9%</font>Â AH after reaching agreement with a syndicate of underwriters for a bought deal to raise at least $500M.</li>     <li>The banks will buy 30.125M shares at $16.60 each, with an option to purchase another 4.518M shares 30 days  after the offering closes.</li>\n<li>SLW plans to use the proceeds to repay a line of credit drawn in November for the $900M purchase of future silver production at the Antamina mine in  Peru.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170511\" data-linked=\"Silver Wheaton -6% on $500M bought-deal financing plan\" data-tweet=\"$WPM - Silver Wheaton -6% on $500M bought-deal financing plan https://seekingalpha.com/news/3170511-silver-wheatonminus-6-on-500m-bought-deal-financing-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3170511-silver-wheatonminus-6-on-500m-bought-deal-financing-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170507\" data-ts=\"1459373972\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170507-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li>\n<b>Top gainers, as of 5.25 p.m.:</b> <a href=\"https://seekingalpha.com/symbol/MDVN\" title=\"Medivation, Inc.\">MDVN</a> <font color=\"green\">+13.9%</font>. <a href=\"https://seekingalpha.com/symbol/VALE\" title=\"Vale S.A.\">VALE</a> <font color=\"green\">+13.4%</font>. <a href=\"https://seekingalpha.com/symbol/EPE\" title=\"EP Energy Corporation\">EPE</a> <font color=\"green\">+12.0%</font>. <a href=\"https://seekingalpha.com/symbol/AU\" title=\"AngloGold Ashanti Limited\">AU</a> <font color=\"green\">+4.6%</font>. <a href=\"https://seekingalpha.com/symbol/WBMD\" title=\"WebMD Health Corp\">WBMD</a> <font color=\"green\">+3.5%</font>.</li>\n<li>\n<b>Top losers, as of 5.25p.m.:</b> <a href=\"https://seekingalpha.com/symbol/PRGS\" title=\"Progress Software Corporation\">PRGS</a> <font color=\"red\">-10.6%</font>. <a href=\"https://seekingalpha.com/symbol/VRNT\" title=\"Verint Systems Inc.\">VRNT</a> <font color=\"red\">-6.6%</font>. SLW <font color=\"red\">-5.9%</font>. <a href=\"https://seekingalpha.com/symbol/OHI\" title=\"Omega Healthcare Investors, Inc\">OHI</a> <font color=\"red\">-1.6%</font>. <a href=\"https://seekingalpha.com/symbol/MAS\" title=\"Masco Corporation\">MAS</a> <font color=\"red\">-1.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170507\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$MDVN $VALE $EPEG - After Hours Gainers / Losers https://seekingalpha.com/news/3170507-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3170507-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170493\" data-ts=\"1459372297\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LIFE\" target=\"_blank\">LIFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170493-atyr-pharma-misses-0_16\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">aTyr Pharma misses by $0.16</a></h4><ul>\n<li>aTyr Pharma (NASDAQ:<a href=\"https://seekingalpha.com/symbol/LIFE\" title=\"aTyr Pharma\">LIFE</a>): Q4 EPS of -$0.70 <font color=\"red\">misses by $0.16</font>.</li>\n<li>Shares <font color=\"green\">+15.2%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170493\" data-linked=\"aTyr Pharma misses by $0.16\" data-tweet=\"$LIFE - aTyr Pharma misses by $0.16 https://seekingalpha.com/news/3170493-atyr-pharma-misses-0_16?source=tweet\" data-url=\"https://seekingalpha.com/news/3170493-atyr-pharma-misses-0_16\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170459\" data-ts=\"1459370245\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATVI\" target=\"_blank\">ATVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170459-hilliard-lyons-downgrades-activision-still-likes-long-term-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hilliard Lyons downgrades Activision, still likes long-term outlook</a></h4><ul>   <li>Activision Blizzard (<a href=\"https://seekingalpha.com/symbol/ATVI\" title=\"Activision Blizzard, Inc\">ATVI</a> <font color=\"green\">+2.5%</font>) has gotten a slight downgrade from Hilliard Lyons after an impressive six weeks has raised its valuation.</li>    <li>Shares have <font color=\"green\">gained 11.6%</font> since Feb. 12. Hilliard Lyons has reduced its rating from Buy to Long-Term Buy, with a valuation that \"<a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/03/7777761/hilliard-lyons-downgrades-activision-still-likes-long-te\" target=\"_blank\">remains attractive</a> despite the recent share price gains.\" The firm set a new two-year price target of $40, with Activision hitting its old one of $34.</li>    <li>Along with \"creating new revenue streams in high-growth areas such as mobile gaming and e-sports (competitive gaming),\" analyst Jeffrey Thomison notes, the company has a strong product pipeline ahead, with new entries in its <i>Call of Duty</i> and <i>Destiny</i> franchises alongside new entries like <i>Overwatch.</i>\n</li>    <li>Thomison sees non-GAAP EPS of $1.75 for the coming year and revenues of $6.26B after including the impact of the King Digital acquisition.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170459\" data-linked=\"Hilliard Lyons downgrades Activision, still likes long-term outlook\" data-tweet=\"$ATVI - Hilliard Lyons downgrades Activision, still likes long-term outlook https://seekingalpha.com/news/3170459-hilliard-lyons-downgrades-activision-still-likes-long-term-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3170459-hilliard-lyons-downgrades-activision-still-likes-long-term-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170436\" data-ts=\"1459368704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170436-micron-technology-beats-0_03-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron Technology beats by $0.03, misses on revenue</a></h4><ul>\n<li>Micron Technology (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MU\" title=\"Micron Technology Inc.\">MU</a>): FQ2 EPS of -$0.05 <font color=\"green\">beats by $0.03</font>.</li>\n<li>Revenue of $2.93B (-29.7% Y/Y) <font color=\"red\">misses by $120M</font>.</li>\n<li>Shares <font color=\"green\">+4%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170436\" data-linked=\"Micron Technology beats by $0.03, misses on revenue\" data-tweet=\"$MU - Micron Technology beats by $0.03, misses on revenue https://seekingalpha.com/news/3170436-micron-technology-beats-0_03-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3170436-micron-technology-beats-0_03-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170433\" data-ts=\"1459368598\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FR\" target=\"_blank\">FR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170433-first-industrial-realty-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Industrial Realty with capital raise</a></h4><ul>\n<li>The company is selling 5.6M shares in a secondary offering.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/FR\" title=\"First Industrial Realty Trust, Inc.\">FR</a>Â <font color=\"red\">-1.15%</font>Â after hours</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170433\" data-linked=\"First Industrial Realty with capital raise\" data-tweet=\"$FR - First Industrial Realty with capital raise https://seekingalpha.com/news/3170433-first-industrial-realty-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3170433-first-industrial-realty-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170426\" data-ts=\"1459367981\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZUR\" target=\"_blank\">AZUR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170426-azure-midstream-says-10-k-to-include-going-concern-paragraph\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Azure Midstream says 10-K to include going concern paragraph</a></h4><ul>     <li>Azure Midstream Partners (<a href='https://seekingalpha.com/symbol/AZUR' title='Azure Midstream Partners, LP'>AZUR</a> <font color='red'>-13.5%</font>) is sharply lower after reporting <a href=\"https://seekingalpha.com/news/3170212-azure-midstream-partners-misses-revenue\" target=\"_blank\">Q4 results</a>, including distributable cash flow of $0.38/unit and revenues of $18.1M.</li>     <li>AZUR says it has $14.4M of cash  on hand and intends to keep $9M in minimum liquidity through June 30, and believes that cash generated from operations will be sufficient to sustain operations.</li>     <li>However, AZUR says it does not expect to remain in compliance with all financial covenants and ratios in its credit agreement throughout 2016 unless requirements are waived or amended, thus its annual 10-K filing will include going concern language.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170426\" data-linked=\"Azure Midstream says 10-K to include going concern paragraph\" data-tweet=\"$AZUR - Azure Midstream says 10-K to include going concern paragraph https://seekingalpha.com/news/3170426-azure-midstream-says-10-k-to-include-going-concern-paragraph?source=tweet\" data-url=\"https://seekingalpha.com/news/3170426-azure-midstream-says-10-k-to-include-going-concern-paragraph\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170420\" data-ts=\"1459367129\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRP\" target=\"_blank\">TRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170420-transcanada-upgraded-to-buy-citi-earnings-become-less-cyclical\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TransCanada upgraded to Buy at Citi as earnings become less cyclical</a></h4><ul>     <li>TransCanada (<a href=\"https://seekingalpha.com/symbol/TRP\" title=\"TransCanada Corporation\">TRP</a> <font color=\"green\">+3.5%</font>) is <a href=\"http://business.financialpost.com/investing/trading-desk/transcanada-corp-upgraded-as-earnings-to-become-less-cyclical\" target=\"_blank\">upgraded to Buy</a> from Neutral with a $55 price target, raised from $50, at Citigroup after the company's moves to reduce the cyclical nature of its earnings.</li>     <li>Citi analyst Faisel Khan sees \"the potential for a re-rating of the stock\" following TRP's solid entry point into Columbia Pipeline and an upcoming sale of its power assets, which the firm estimates could fetch as much as $4B; meanwhile, the 49% stake in TRP's Mexican natural gas pipelines could attract ~$2B.</li>     <li>Khan also notes that TRP trades at one of the lower 2018 P/E multiples among large-cap pipelines and utilities.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170420\" data-linked=\"TransCanada upgraded to Buy at Citi as earnings become less cyclical\" data-tweet=\"$TRP - TransCanada upgraded to Buy at Citi as earnings become less cyclical https://seekingalpha.com/news/3170420-transcanada-upgraded-to-buy-citi-earnings-become-less-cyclical?source=tweet\" data-url=\"https://seekingalpha.com/news/3170420-transcanada-upgraded-to-buy-citi-earnings-become-less-cyclical\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170418\" data-ts=\"1459366217\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLR\" target=\"_blank\">CLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170418-seaport-global-upgrades-seven-downgrades-11-oil-producers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seaport Global upgrades seven, downgrades 11 oil producers</a></h4><ul>     <li>Analysts at Seaport Global <a href=\"http://blogs.barrons.com/stockstowatchtoday/2016/03/30/holy-cow-these-analysts-just-upgraded-seven-oil-stocks-to-buy-and-cut-11-others/\" target=\"_blank\">upgrade seven oil and gas producers</a>, advocating for increased exposure to select names they say should protect investors in the event of a move back toward $50/bbl, while downgrading 11 others.</li>     <li>Seaport upgrades seven companies to Buy: Continental Resources (<a href=\"https://seekingalpha.com/symbol/CLR\" title=\"Continental Resources, Inc.\">CLR</a> <font color=\"green\">+3.4%</font>), Callon Petroleum (<a href=\"https://seekingalpha.com/symbol/CPE\" title=\"Callon Petroleum Co.\">CPE</a> <font color=\"green\">+1.4%</font>), Marathon Oil (<a href=\"https://seekingalpha.com/symbol/MRO\" title=\"Marathon Oil Corporation\">MRO</a> <font color=\"green\">+1.9%</font>), Oasis Petroleum (<a href=\"https://seekingalpha.com/symbol/OAS\" title=\"Oasis Petroleum Inc.\">OAS</a> <font color=\"green\">+2.8%</font>), Rice Energy (<a href=\"https://seekingalpha.com/symbol/RICE\" title=\"Rice Energy Inc\">RICE</a> <font color=\"green\">+1.7%</font>), Petroquest Energy (<a href=\"https://seekingalpha.com/symbol/PQ\" title=\"PetroQuest Energy Inc.\">PQ</a> <font color=\"green\">+9.1%</font>) and Lonestar Resources (LNREF <font color=\"green\">+6.6%</font>).</li>     <li>Downgraded to Sell are Whiting Petroleum (<a href=\"https://seekingalpha.com/symbol/WLL\" title=\"Whiting Petroleum Corporation\">WLL</a> <font color=\"green\">+4.1%</font>), Southwestern Energy (<a href=\"https://seekingalpha.com/symbol/SWN\" title=\"Southwestern Energy Co.\">SWN</a> <font color=\"red\">-2.5%</font>), WPX Energy (<a href=\"https://seekingalpha.com/symbol/WPX\" title=\"WPX Energy, Inc.\">WPX</a> <font color=\"green\">+0.6%</font>), Laredo Petroleum (<a href=\"https://seekingalpha.com/symbol/LPI\" title=\"Laredo Petroleum Holdings, Inc.\">LPI</a> <font color=\"red\">-1.1%</font>), Jones Energy (<a href=\"https://seekingalpha.com/symbol/JONE\" title=\"Jones Energy, Inc.\">OTC:JONE</a> <font color=\"green\">+0.9%</font>), Northern Oil &amp; Gas (<a href=\"https://seekingalpha.com/symbol/NOG\" title=\"Northern Oil &amp; Gas, Inc\">NOG</a> <font color=\"green\">+1%</font>), Carrizo Oil &amp;Â Gas (<a href=\"https://seekingalpha.com/symbol/CRZO\" title=\"Carrizo Oil &amp; Gas, Inc.\">CRZO</a> <font color=\"green\">+1.6%</font>), Memorial Resource (<a href=\"https://seekingalpha.com/symbol/MRD\" title=\"Memorial Resource Development Corp.\">MRD</a> <font color=\"green\">+2.5%</font>), Matador Resources (<a href=\"https://seekingalpha.com/symbol/MTDR\" title=\"Matador Resources\">MTDR</a> <font color=\"red\">-0.3%</font>), Sanchez Energy (<a href=\"https://seekingalpha.com/symbol/SN\" title=\"Sanchez Energy Corporation\">SN</a> <font color=\"green\">+1.6%</font>) and PDCÂ Energy (<a href=\"https://seekingalpha.com/symbol/PDCE\" title=\"PDC Energy, Inc.\">PDCE</a> <font color=\"red\">-0.9%</font>).</li>     <li>The firm also favors gaining leverage to the Oklahoma STACK play, thus CLR and Newfield Exploration (<a href=\"https://seekingalpha.com/symbol/NFX\" title=\"Newfield Exploration Co.\">NFX</a> <font color=\"green\">+1.9%</font>) have \"taken the pole position away\" from Permian producers Parsley Energy (<a href=\"https://seekingalpha.com/symbol/PE\" title=\"Parsley Energy, Inc.\">PE</a> <font color=\"green\">+1.3%</font>) and Pioneer Natural Resources (<a href=\"https://seekingalpha.com/symbol/PXD\" title=\"Pioneer Natural Resources Company\">PXD</a> <font color=\"green\">+1%</font>).</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3170418\" data-linked=\"Seaport Global upgrades seven, downgrades 11 oil producers\" data-tweet=\"$CLR $CLR $CPE - Seaport Global upgrades seven, downgrades 11 oil producers https://seekingalpha.com/news/3170418-seaport-global-upgrades-seven-downgrades-11-oil-producers?source=tweet\" data-url=\"https://seekingalpha.com/news/3170418-seaport-global-upgrades-seven-downgrades-11-oil-producers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170409\" data-ts=\"1459362965\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USCR\" target=\"_blank\">USCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170409-u-s-concreteminus-6-amid-negative-streetsweeper-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Concrete -6% amid negative StreetSweeper report</a></h4><ul>     <li>U.S. Concrete (<a href=\"https://seekingalpha.com/symbol/USCR\" title=\"US Concrete Inc.\">USCR</a> <font color=\"red\">-5.9%</font>) stumbles following a StreetSweeper report that says shares are set to \"<a href=\"http://thestreetsweeper.org/undersurveillance/US_Concrete__Ready_To_Crack_Under_Pressure\" target=\"_blank\">go down, down, down</a>\" following a near 20% YTD return and a more than 80% rally over the past year.</li>     <li>The report says shares are trading at an \"incredible\" P/E ratio of 544, which implies that investors are paying 22x for USCR than the average 24 P/E seen within the broader industry, and that the nearly $1B market valuation placed on the company is \"outlandish.\"</li>     <li>Insiders have picking up the pace of sales in recent months, suggesting shares may be overvalued at ~$55/share, according to the report.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170409\" data-linked=\"U.S. Concrete -6% amid negative StreetSweeper report\" data-tweet=\"$USCR - U.S. Concrete -6% amid negative StreetSweeper report https://seekingalpha.com/news/3170409-u-s-concreteminus-6-amid-negative-streetsweeper-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3170409-u-s-concreteminus-6-amid-negative-streetsweeper-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170394\" data-ts=\"1459357918\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TYEKF\" target=\"_blank\">TYEKF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170394-thyssenkrupp-surges-tata-steel-prepares-to-sell-u-k-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ThyssenKrupp surges as Tata Steel prepares to sell U.K. business</a></h4><ul>\n<li>German steel producer ThyssenKrupp (<a href=\"https://seekingalpha.com/symbol/TYEKF\" title=\"ThyssenKrupp AG\">OTCPK:TYEKF</a>) <a href=\"http://www.marketwatch.com/story/thyssenkrupp-powers-higher-as-tata-prepares-to-scuttle-uk-business-2016-03-30\" target=\"_blank\">jumped more than 8% today</a> in Europe after India's Tata Steel said the slump in global prices has forced it to considerÂ <a href=\"http://www.bloomberg.com/news/articles/2016-03-29/tata-steel-to-study-sale-of-u-k-unit-after-strategic-review\" target=\"_blank\">selling its loss-making U.K. operations</a>.</li>\n<li>Tata\u2019s exit from the U.K. might result in consolidation in the European steel industry, and a combination of Tata and ThyssenKrupp \u201cmay now become more than just a hypothesis,\u201d says Berenberg analysts as they reiterate a Buy rating on ThyssenKrupp.</li>\n<li>Tata says it has suffered more than Â£2B  ($2.88B) in asset impairments duringÂ  the last five years stemming from its U.K. operations.</li>\n<li>Tata\u2019s U.K. assets, once controlled by British Steel and  bought for $12B a decade ago, include the giant Port Talbot works  in South Wales, and a sale would risk the loss of thousands of industrial jobs in an  economically deprived region.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170394\" data-linked=\"ThyssenKrupp surges as Tata Steel prepares to sell U.K. business\" data-tweet=\"$TYEKF - ThyssenKrupp surges as Tata Steel prepares to sell U.K. business https://seekingalpha.com/news/3170394-thyssenkrupp-surges-tata-steel-prepares-to-sell-u-k-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3170394-thyssenkrupp-surges-tata-steel-prepares-to-sell-u-k-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170387\" data-ts=\"1459357024\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIO\" target=\"_blank\">RIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170387-rio-tinto-initiated-buy-rating-argus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rio Tinto initiated with Buy rating at Argus</a></h4><ul>     <li>Rio Tinto (<a href=\"https://seekingalpha.com/symbol/RIO\" title=\"Rio Tinto plc\">RIO</a> <font color=\"green\">+3.4%</font>) is initiated with a <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/03/7775032/argus-initiates-rio-tinto-with-buy-rating-36-target\" target=\"_blank\">Buy rating</a> and a $36 price target at Argus, which looks for improved industry fundamentals and stronger sales and earnings in 2017 even as commodity price weakness weighs on Rio\u2019s results in the near term.</li>     <li>Argus likes Rio's responses to the commodity price downturn - strengthening its operating performance and balance sheet through cost-savings programs, asset sales and capital spending reductions - and believes the announced dividend cut will provide greater financial flexibility.</li>     <li>The firm views Rio's current stock valuation as attractive, given the expectations of a turnaround through 2017.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170387\" data-linked=\"Rio Tinto initiated with Buy rating at Argus\" data-tweet=\"$RIO - Rio Tinto initiated with Buy rating at Argus https://seekingalpha.com/news/3170387-rio-tinto-initiated-buy-rating-argus?source=tweet\" data-url=\"https://seekingalpha.com/news/3170387-rio-tinto-initiated-buy-rating-argus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170385\" data-ts=\"1459356809\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MET\" target=\"_blank\">MET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170385-metlife-victory-surprise-says-analyst\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MetLife victory a surprise, says analyst</a></h4><ul>\n<li>Members of the Financial Stability Oversight Council - which includes Treasury Sec. Jack Lew and Fed chair Janet Yellen - <a href=\"http://www.ft.com/intl/cms/s/0/b171d236-f687-11e5-96db-fc683b5e52db.html?ftcamp=published_links%2Frss%2Fcompanies_financial-services%2Ffeed%2F%2Fproduct#axzz44PD3dZuD\" target=\"_blank\">had voted nine to one</a> in favor of labeling MetLife (<a href=\"https://seekingalpha.com/symbol/MET\" title=\"MetLife, Inc.\">MET</a> <font color=\"green\">+4.8%</font>) a systemically important financial institution, but a federal court found the government acted unlawfully.</li>\n<li>The government, of course, could tie things up with for years with appeals.</li>\n<li>FBR's Weston Bloomber calls the ruling in favor of MetLife a surprise. Nevertheless, most expect the insurer to move forward with plans to sell its U.S. retail life insurance business.</li>\n<li>Neither MetLife nor the government has commented on the ruling, which remains sealed until the parties agree on what to keep confidential.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3170354-prudential-aig-move-metlife-wins-sifi-case\" target=\"_blank\">Prudential and AIG on the move as MetLife wins SIFI case</a> (March 30)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3170352-metlife-flies-judge-shoots-sifi-label\" target=\"_blank\">MetLife flies as judge shoots down SIFI label</a> (March 30)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170385\" data-linked=\"MetLife victory a surprise, says analyst\" data-tweet=\"$MET - MetLife victory a surprise, says analyst https://seekingalpha.com/news/3170385-metlife-victory-surprise-says-analyst?source=tweet\" data-url=\"https://seekingalpha.com/news/3170385-metlife-victory-surprise-says-analyst\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170384\" data-ts=\"1459356377\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170384-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers/ Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/DRWI' title='DragonWave Inc.'>DRWI</a> <font color='green'>+38%</font>. <a href='https://seekingalpha.com/symbol/STAF' title='Staffing 360 Solutions, Inc.'>STAF</a> <font color='green'>+28%</font>. ARGS <font color='green'>+18%</font>. ADK <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/IOC' title='InterOil Corporation'>IOC</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/LEU' title='Centrus Energy Corp.'>LEU</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/TEGP-OLD' title='Tallgrass Energy GP LP'>TEGP-OLD</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/GGB' title='Gerdau S.A.'>GGB</a> <font color='green'>+11%</font>. YOD <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/NFEC' title='NF Energy Saving Corp.'>NFEC</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/VRNT' title='Verint Systems Inc.'>VRNT</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/DLHC' title='DLH Holdings Corp'>DLHC</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/AZUR' title='Azure Midstream Partners, LP'>AZUR</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/ICLD-OLD' title='InterCloud Systems, Inc.'>ICLD</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/SBOT' title='Stellar Biotechnologies Inc.'>SBOT</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/FORM' title='FormFactor, Inc.'>FORM</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ATHX' title='Athersys, Inc.'>ATHX</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170384\" data-linked=\"Midday Gainers/ Losers\" data-tweet=\"$DRWI $STAF $ARGSQ - Midday Gainers/ Losers https://seekingalpha.com/news/3170384-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3170384-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170383\" data-ts=\"1459356332\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/E\" target=\"_blank\">E</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170383-eni-confirms-three-deaths-from-niger-delta-oil-pipeline-explosion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eni confirms three deaths from Niger Delta oil pipeline explosion</a></h4><ul>     <li>Eni (<a href=\"https://seekingalpha.com/symbol/E\" title=\"ENI S.p.A.\">E</a> <font color=\"green\">+2.7%</font>) confirms that <a href=\"http://www.wsj.com/articles/eni-confirms-deaths-near-damaged-niger-delta-oil-pipeline-1459354829\" target=\"_blank\">three people died</a> when one of its oil pipelines in the Niger Delta region in Nigeria exploded during repair works.</li>     <li>Eni believes the pipeline was damaged during an act of sabotage on March 24, after which production was shut and repair works were carried out; the repairs were concluded on Saturday, but the bodies not found until Sunday.</li>     <li>Nigeria has suffered several attacks on pipelines in recent months, caused by attempted oil theft, including two refineries shut in January because of sabotage.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170383\" data-linked=\"Eni confirms three deaths from Niger Delta oil pipeline explosion\" data-tweet=\"$E - Eni confirms three deaths from Niger Delta oil pipeline explosion https://seekingalpha.com/news/3170383-eni-confirms-three-deaths-from-niger-delta-oil-pipeline-explosion?source=tweet\" data-url=\"https://seekingalpha.com/news/3170383-eni-confirms-three-deaths-from-niger-delta-oil-pipeline-explosion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170382\" data-ts=\"1459355848\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JAZZ\" target=\"_blank\">JAZZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170382-fda-clears-jazz-pharmas-defitelio-for-hepatic-vod-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA clears Jazz Pharma&#39;s Defitelio for hepatic VOD; shares up 3%</a></h4><ul>\n<li>The FDA <a href=\"http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm493225.htm\" target=\"_blank\">approves </a>Jazz Pharmaceuticals' (<a href=\"https://seekingalpha.com/symbol/JAZZ\" title=\"Jazz Pharmaceuticals, Inc.\">JAZZ</a> <font color=\"green\">+2.5%</font>) Defitelio (defibrotide sodium) for the treatment of adults and children who develop hepatic veno-occlusive disease (VOD), with additional kidney or lung problems, following hematopoietic stem cell transplantation (HSCT). This is the first FDA-approved therapy for the rare and life-threatening condition.</li>\n<li>In clinical studies supporting the New Drug Application (NDA), 38 - 45% patients with hepatic VOD and liver or kidney abnormalities were still alive 100 days after HSCT, compared to 21 - 31% of patients who received other supportive care or interventions (according to published literature).</li>\n<li>Serious adverse events reported included bleeding and allergic reactions.</li>\n<li>\n<a href=\"https://www.merckmanuals.com/home/liver-and-gallbladder-disorders/blood-vessel-disorders-of-the-liver/veno-occlusive-disease-of-the-liver\" target=\"_blank\">Hepatic VOD</a> occurs when some of the veins in the liver become blocked, causing swelling and decreased blood flow in the liver leading to potential organ damage. In extreme cases (fewer than 2% of HSCT patients), the person may experience kidney and/or lung failure.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170382\" data-linked=\"FDA clears Jazz Pharma&#39;s Defitelio for hepatic VOD; shares up 3%\" data-tweet=\"$JAZZ - FDA clears Jazz Pharma&#39;s Defitelio for hepatic VOD; shares up 3% https://seekingalpha.com/news/3170382-fda-clears-jazz-pharmas-defitelio-for-hepatic-vod-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3170382-fda-clears-jazz-pharmas-defitelio-for-hepatic-vod-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170380\" data-ts=\"1459355719\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSC-OLD\" target=\"_blank\">SSC-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170380-you-on-demandplus-11-after-narrower-q4-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">You On Demand +11% after narrower Q4 loss</a></h4><ul>   <li>Video on demand provider You On Demand (YOD) is <font color=\"green\">up 11.1%</font> after <a href=\"https://seekingalpha.com/news/3170301-demand-reports-q4-results\" target=\"_blank\">Q4 earnings results</a> where it posted a narrower net loss (for the quarter and the year) and boosted revenues 241% from Q3.</li>    <li>Revenue for the year rose 135% from 2014, to $4.6M.</li>    <li>Current assets at year-end were $10.1M; cash didn't include the $10M in proceeds the company received from an investment by Bruno Wu and Beijing Sun Seven Stars Culture Development Limited.</li>    <li>\n<a href=\"http://corporate.yod.com/\" target=\"_blank\">Conference call</a> to come at 4:30 p.m. ET.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3170380\" data-linked=\"You On Demand +11% after narrower Q4 loss\" data-tweet=\"$SSC-OLD - You On Demand +11% after narrower Q4 loss https://seekingalpha.com/news/3170380-you-on-demandplus-11-after-narrower-q4-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3170380-you-on-demandplus-11-after-narrower-q4-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170379\" data-ts=\"1459355530\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIG\" target=\"_blank\">AIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170379-janneys-aig-upgrade-management-gets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Janney&#39;s AIG upgrade: Management gets it</a></h4><ul>\n<li>\"Management possesses an understanding of its challenges and the resolve to improve returns that heretofore was lacking,\" <a href=\"http://blogs.barrons.com/stockstowatchtoday/2016/03/30/american-international-group-a-strategy-worthy-of-an-upgrade/?mod=BOL_hp_blog_stw\" target=\"_blank\">says Janney's Larry Greenberg</a>, upgrading AIG (<a href=\"https://seekingalpha.com/symbol/AIG\" title=\"American International Group Inc\">AIG</a> <font color=\"green\">+2%</font>) to Buy from Neutral after meeting with executives at the insurer. \"It also appears that investor expectations have been significantly reduced.\"</li>\n<li>Greenberg and team left the meeting with a higher level of confidence in the quality of the expected underwriting improvement, though not enough yet to boost 2016 or 2017 estimates. \"Operating improvements will likely be uneven over the next couple of years and the company will certainly face a number of earnings headwinds, such as reduced investment income from its various restructuring activities.\"</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3170354-prudential-aig-move-metlife-wins-sifi-case\" target=\"_blank\">Prudential and AIG on the move as MetLife wins SIFI case</a> (March 30)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3170294-aig-gives-icahn-pay-upgraded-janney\" target=\"_blank\">AIG gives in to Icahn on pay, upgraded at Janney</a> (March 30)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170379\" data-linked=\"Janney&#39;s AIG upgrade: Management gets it\" data-tweet=\"$AIG - Janney&#39;s AIG upgrade: Management gets it https://seekingalpha.com/news/3170379-janneys-aig-upgrade-management-gets?source=tweet\" data-url=\"https://seekingalpha.com/news/3170379-janneys-aig-upgrade-management-gets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170377\" data-ts=\"1459354695\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNR\" target=\"_blank\">VNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170377-vanguard-natural-to-sell-oklahoma-sccop-stack-assets-for-280m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vanguard Natural to sell Oklahoma SCCOP/STACK assets for $280M</a></h4><ul>     <li>Vanguard Natural Resources (<a href=\"https://seekingalpha.com/symbol/VNR\" title=\"Vanguard Natural Resources, LLC\">VNR</a> <font color=\"green\">+11.7%</font>) agrees to sell its natural gas, oil and natural gas liquids assets in Oklahoma's SCOOP/STACK area for $280M to entities managed by Titanium Exploration Partners.</li>     <li>VNR says it expects to close the deal by May 18, when it plans to provide updated operating and financial guidance for 2016.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170377\" data-linked=\"Vanguard Natural to sell Oklahoma SCCOP/STACK assets for $280M\" data-tweet=\"$VNR - Vanguard Natural to sell Oklahoma SCCOP/STACK assets for $280M https://seekingalpha.com/news/3170377-vanguard-natural-to-sell-oklahoma-sccop-stack-assets-for-280m?source=tweet\" data-url=\"https://seekingalpha.com/news/3170377-vanguard-natural-to-sell-oklahoma-sccop-stack-assets-for-280m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170375\" data-ts=\"1459353559\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XCO\" target=\"_blank\">XCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170375-exco-resources-cuts-capex-plan-69-says-borrowing-base-cut-13\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exco Resources cuts capex plan by 69%, says borrowing base cut by 13%</a></h4><ul>     <li>Exco Resources (<a href=\"https://seekingalpha.com/symbol/XCO\" title=\"EXCO Resources, Inc.\">XCO</a> <font color=\"red\">-2%</font>) says it will cut planned 2016 capex by 69% Y/Y and says its lenders have reduced its borrowing base by 13% due to weak oil prices.</li>     <li>XCO says it plans a capital budget of $85M, as it  will \u201csignificantly reduce\u201d its drilling activity and is \u201cdeferring a  significant amount\u201d of its drilling inventory until commodity prices  increase.</li>     <li>The company expects to drill seven wells and complete 15 wells during the year, focusing on north Louisiana and east Texas.</li>     <li>XCO also says its lenders cut its borrowing base to $325M from $375M previously during a regular redetermination process.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170375\" data-linked=\"Exco Resources cuts capex plan by 69%, says borrowing base cut by 13%\" data-tweet=\"$XCO - Exco Resources cuts capex plan by 69%, says borrowing base cut by 13% https://seekingalpha.com/news/3170375-exco-resources-cuts-capex-plan-69-says-borrowing-base-cut-13?source=tweet\" data-url=\"https://seekingalpha.com/news/3170375-exco-resources-cuts-capex-plan-69-says-borrowing-base-cut-13\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170372\" data-ts=\"1459353336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHAK\" target=\"_blank\">SHAK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170372-shake-shack-perks-up-after-longbow-turns-bullish\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shake Shack perks up after Longbow turns bullish</a></h4><ul> <li>Shake Shack (<a href=\"https://seekingalpha.com/symbol/SHAK\" title=\"Shake Shack\">SHAK</a> <font color=\"green\">+3.2%</font>) is extending on yesterday's rally after Longbow Research <a href=\"http://fortune.com/2016/03/30/why-this-analyst-says-you-should-buy-shake-shack/\" target=\"_blank\">upgraded</a> the restaurant stock to a Buy rating.</li> <li>The investment firm thinks Shake Shack's 2016 same-store sales forecast of 2.5% to 3.5% doesn't factor in some added sales from the new Chick'n Shack sandwich.</li> <li>Longbow's price target of $46 implies Shake Shack still has plenty of upside. Shares of Shack Shack have been under $40 for a majority of this year.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3170372\" data-linked=\"Shake Shack perks up after Longbow turns bullish\" data-tweet=\"$SHAK - Shake Shack perks up after Longbow turns bullish https://seekingalpha.com/news/3170372-shake-shack-perks-up-after-longbow-turns-bullish?source=tweet\" data-url=\"https://seekingalpha.com/news/3170372-shake-shack-perks-up-after-longbow-turns-bullish\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170369\" data-ts=\"1459353177\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170369-sarepta-gets-modest-bump-from-edelmans-bullish-comments-on-cnbc-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta gets modest bump from Edelman&#39;s bullish comments on CNBC; shares up 1%</a></h4><ul>\n<li>Sarepta Therapeutics (<a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a> <font color=\"green\">+0.8%</font>) bucks biotech's down day on average volume. On CNBC, hedge fund manage Joe Edelman re-emphasized his confidence that DMD candidate eteplirsen will be approved by the FDA.</li>\n<li>The Ad Comm review is scheduled for April 25 followed by the PDUFA date on May 26.</li>\n<li>This is a superb example of the prominence (risk)Â of a binary event for biotech investors. It will be either feast or famine. BioMarin Pharmaceutical (<a href=\"https://seekingalpha.com/symbol/BMRN\" title=\"BioMarin Pharmaceutical Inc.\">BMRN</a> <font color=\"red\">-0.4%</font>) longs felt the sting of rejection a few months ago with its DMD candidate drisapersen.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3031396-fda-rejects-biomarins-drisapersen-duchenne-muscular-dystrophy\" target=\"_blank\">FDA rejects BioMarin's drisapersen for Duchenne muscular dystrophy</a> (Jan. 14)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2950986-ad-comm-fails-back-biomarins-drisapersen-dmd\" target=\"_blank\">Ad Comm fails to back BioMarin's drisapersen for DMD</a> (Nov. 24, 2015)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170369\" data-linked=\"Sarepta gets modest bump from Edelman&#39;s bullish comments on CNBC; shares up 1%\" data-tweet=\"$SRPT $SRPT $BMRN - Sarepta gets modest bump from Edelman&#39;s bullish comments on CNBC; shares up 1% https://seekingalpha.com/news/3170369-sarepta-gets-modest-bump-from-edelmans-bullish-comments-on-cnbc-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3170369-sarepta-gets-modest-bump-from-edelmans-bullish-comments-on-cnbc-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170370\" data-ts=\"1459352992\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KGC\" target=\"_blank\">KGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170370-kinross-gold-to-proceed-first-phase-of-tasiast-mine-expansion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kinross Gold to proceed with first phase of Tasiast mine expansion</a></h4><ul>     <li>Kinross Gold (<a href=\"https://seekingalpha.com/symbol/KGC\" title=\"Kinross Gold Corporation\">KGC</a> <font color=\"red\">-2.5%</font>) says it will go ahead with the expansion of the Tasiast gold mine in Mauritania, expecting to spend $300M on the first expansion phase plus ~$428M in costs for stripping for a total cost of $728M.</li>\n<li>As a result, KGC expects total 2016 capex will rise to $755M from the $595M it forecast last  month.</li>\n<li>The first phase of the expansion is expected to increase mill throughput capacity to 12K metric tons/day from 8K metric tons/day.</li>\n<li>Once the first part of the expansion is complete, Tasiast will have  all-in-sustaining costs of $760/oz., compared with current production  costs of ~$1,400/oz., CEO Paul Rollinson says.</li>\n<li>\n<a href=\"http://www.bloomberg.com/news/articles/2016-03-30/kinross-gold-to-proceed-with-first-phase-of-tasiast-expansion\" target=\"_blank\">Developing the mine is essential</a> to keeping KGC\u2019s  production levels stable, as the company\u2019s  Fort Knox operation in Alaska and Round Mountain mine in Nevada are both  nearing the end of their lives, BMO analyst Andrew Kaip says.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3170370\" data-linked=\"Kinross Gold to proceed with first phase of Tasiast mine expansion\" data-tweet=\"$KGC - Kinross Gold to proceed with first phase of Tasiast mine expansion https://seekingalpha.com/news/3170370-kinross-gold-to-proceed-first-phase-of-tasiast-mine-expansion?source=tweet\" data-url=\"https://seekingalpha.com/news/3170370-kinross-gold-to-proceed-first-phase-of-tasiast-mine-expansion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170359\" data-ts=\"1459350461\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLOFY\" target=\"_blank\">GLOFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170359-gameloft-ceo-family-may-increase-stake-to-resist-vivendi\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gameloft CEO: Family may increase stake to resist Vivendi</a></h4><ul>   <li>The founding Guillemot family may be <a href=\"http://www.reuters.com/article/us-gameloft-m-a-vivendi-idUSKCN0WV1LD?feedType=nl&amp;feedName=innovationNews\" target=\"_blank\">increasing its stake</a> in game maker Gameloft (<a href='https://seekingalpha.com/symbol/GLOFY' title='Gameloft SA ADR'>OTCPK:GLOFY</a>) in an effort to resist a hostile tender offer from Vivendi (<a href='https://seekingalpha.com/symbol/VIVHY' title='Vivendi SA ADR'>OTCPK:VIVHY</a> <font color='green'>+0.8%</font>).</li>    <li>CEO Michel Guillemot told <i>Le Monde:</i> \"We could go on ... We don't have much debt.\"</li>    <li>Vivendi has been in pursuit of Gameloft and Ubisoft (<a href='https://seekingalpha.com/symbol/UBSFY' title='UbiSoft Entertainment Inc. ADR'>OTCPK:UBSFY</a> <font color='green'>+3.6%</font>) -- also founded by the Guillemots -- by increasing stakes in the two amid growing speculation that takeover bids were coming.</li>    <li>Vivendi launched a tender for Gameloft after it crossed the 30% stake threshold. It raised its offer to &euro;7.20/share on Feb. 29; shares are trading in Paris today up 2.6% to &euro;7.52. Vivendi also owns 15.66% of Ubisoft.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170359\" data-linked=\"Gameloft CEO: Family may increase stake to resist Vivendi\" data-tweet=\"$GLOFY $GLOFY $VIVHY - Gameloft CEO: Family may increase stake to resist Vivendi https://seekingalpha.com/news/3170359-gameloft-ceo-family-may-increase-stake-to-resist-vivendi?source=tweet\" data-url=\"https://seekingalpha.com/news/3170359-gameloft-ceo-family-may-increase-stake-to-resist-vivendi\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170356\" data-ts=\"1459349821\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVX\" target=\"_blank\">CVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170356-reuters-nigeria-seeks-help-in-revamping-refineries-from-chveron-total-eni\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Nigeria seeks help in revamping refineries from Chveron, Total, Eni</a></h4><ul>     <li>Nigeria is in talks with Chevron (<a href=\"https://seekingalpha.com/symbol/CVX\" title=\"Chevron Corporation\">CVX</a> <font color=\"green\">+1.2%</font>), Total (<a href=\"https://seekingalpha.com/symbol/TOT\" title=\"TOTAL S.A.\">TOT</a> <font color=\"green\">+2.8%</font>) and Eni (<a href=\"https://seekingalpha.com/symbol/E\" title=\"ENI S.p.A.\">E</a> <font color=\"green\">+4%</font>) to get help in <a href=\"http://uk.reuters.com/article/uk-nigeria-oil-refineries-idUKKCN0WV2N3\" target=\"_blank\">revamping the country's aging refineries</a>, the oil minister tells Reuters.</li>     <li>The country, Africa's top crude oil producer, has been trying to restart its outdated refineries in Port Harcourt, Warri and Kaduna to end its dependency on costly fuel imports.</li>     <li>The minister also says the state-run oil firm NNPC has reached deals with oil majors, with which it works in joint ventures, to help make up for a shortage of dollars due to a slump in oil revenues hindering fuel imports.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170356\" data-linked=\"Reuters: Nigeria seeks help in revamping refineries from Chveron, Total, Eni\" data-tweet=\"$CVX $CVX $TOT - Reuters: Nigeria seeks help in revamping refineries from Chveron, Total, Eni https://seekingalpha.com/news/3170356-reuters-nigeria-seeks-help-in-revamping-refineries-from-chveron-total-eni?source=tweet\" data-url=\"https://seekingalpha.com/news/3170356-reuters-nigeria-seeks-help-in-revamping-refineries-from-chveron-total-eni\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170354\" data-ts=\"1459349677\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRU\" target=\"_blank\">PRU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170354-prudential-and-aig-on-move-metlife-wins-sifi-case\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prudential and AIG on the move as MetLife wins SIFI case</a></h4><ul>\n<li>Unlike MetLife, Prudential (<a href=\"https://seekingalpha.com/symbol/PRU\" title=\"Prudential Financial, Inc.\">PRU</a> <font color=\"green\">+3.5%</font>) and AIG (<a href=\"https://seekingalpha.com/symbol/AIG\" title=\"American International Group Inc\">AIG</a> <font color=\"green\">+2.2%</font>) chose to accept, rather than try and fight The Man over being labeled as systemically important. That's not stopping them from joining in MetLife's rally today as a judge - noting MetLife is already dealing with regulators in 50 states - rescinds the federal government's layering of new rules on top of that.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3170352-metlife-flies-judge-shoots-sifi-label\" target=\"_blank\">MetLife flies as judge shoots down SIFI label</a> (March 30)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170354\" data-linked=\"Prudential and AIG on the move as MetLife wins SIFI case\" data-tweet=\"$PRU $PRU $AIG - Prudential and AIG on the move as MetLife wins SIFI case https://seekingalpha.com/news/3170354-prudential-and-aig-on-move-metlife-wins-sifi-case?source=tweet\" data-url=\"https://seekingalpha.com/news/3170354-prudential-and-aig-on-move-metlife-wins-sifi-case\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170352\" data-ts=\"1459349343\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MET\" target=\"_blank\">MET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170352-metlife-flies-judge-shoots-down-sifi-label\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MetLife flies as judge shoots down SIFI label</a></h4><ul>\n<li>\n<a href=\"https://twitter.com/CNBCnow/status/715188313565564929\" target=\"_blank\">Dow Jones is reporting </a>a federal judge as rescinding the government's labeling of MetLife (<a href=\"https://seekingalpha.com/symbol/MET\" title=\"MetLife, Inc.\">MET</a> <font color=\"green\">+5.6%</font>) as a systemically important financial institution.</li>\n<li>\n<strong>Update</strong>: The court's opinion is sealed, pending a meeting on April 6 between MetLife and the Financial Stability Oversight Council at which they will determine what should remain confidential.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170352\" data-linked=\"MetLife flies as judge shoots down SIFI label\" data-tweet=\"$MET - MetLife flies as judge shoots down SIFI label https://seekingalpha.com/news/3170352-metlife-flies-judge-shoots-down-sifi-label?source=tweet\" data-url=\"https://seekingalpha.com/news/3170352-metlife-flies-judge-shoots-down-sifi-label\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170347\" data-ts=\"1459349164\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDOC\" target=\"_blank\">SDOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170347-sandridge-hires-advisers-to-evaluate-options-including-bankruptcy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SandRidge hires advisers to evaluate options including bankruptcy</a></h4><ul>     <li>SandRidge Energy (<a href=\"https://seekingalpha.com/symbol/SDOC\" title=\"Sandridge Energy, Inc.\">OTCPK:SDOC</a> <font color=\"red\">-10.5%</font>) discloses in its <a href=\"http://www.sec.gov/Archives/edgar/data/1349436/000134943616000213/sd10k12312015.htm\" target=\"_blank\">10-K filing</a> that it has <a href=\"http://www.reuters.com/article/us-sandridge-restructuring-idUSKCN0WW1MB\" target=\"_blank\">engaged advisors</a> to assist with a private restructuring or reorganization under Chapter 11, and says there is substantial doubt about its ability to continue as a going concern.</li>     <li>SDOC is working with law firm Kirkland &amp; Ellis and investment bank Houlihan Lokey on debt restructuring options.</li>     <li>In its <a href=\"https://seekingalpha.com/news/3170147-sandridge-energy-beats-0_03-misses-revenue\" target=\"_blank\">Q4 earnings</a>, SDOC reported a $0.09/share loss vs. an $0.08 profit a year ago, a 59% Y/Y decline in revenues to $143M, adjusted EBITDA of $67M vs. $224M a year ago, and 2016 capex guidance of $285M, ~60% below 2015 levels.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170347\" data-linked=\"SandRidge hires advisers to evaluate options including bankruptcy\" data-tweet=\"$SDOC - SandRidge hires advisers to evaluate options including bankruptcy https://seekingalpha.com/news/3170347-sandridge-hires-advisers-to-evaluate-options-including-bankruptcy?source=tweet\" data-url=\"https://seekingalpha.com/news/3170347-sandridge-hires-advisers-to-evaluate-options-including-bankruptcy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170334\" data-ts=\"1459346423\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTRV\" target=\"_blank\">CTRV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170334-contravir-prices-equity-offering-discount-shares-off-26\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ContraVir prices equity offering at discount; shares off 26%</a></h4><ul>\n<li>ContraVir Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/CTRV\" title=\"ContraVir Pharmaceuticals, Inc.\">CTRV</a> <font color=\"red\">-26.3%</font>) slumps on triple normal volume in response to the pricing of its public offering of 4,929,578 shares of common stock and warrants to purchase 2,464,789 shares of common for a fixed combined price of $1.42, although the stocks and warrants will be issued separately.</li>\n<li>The five-year warrants are exercisable when issued at a price of $1.70 per common share.</li>\n<li>Closing date is April 4.</li>\n<li>\n<strong>Update</strong>: The offering closed on April 4.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170334\" data-linked=\"ContraVir prices equity offering at discount; shares off 26%\" data-tweet=\"$CTRV $HEPA - ContraVir prices equity offering at discount; shares off 26% https://seekingalpha.com/news/3170334-contravir-prices-equity-offering-discount-shares-off-26?source=tweet\" data-url=\"https://seekingalpha.com/news/3170334-contravir-prices-equity-offering-discount-shares-off-26\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170328\" data-ts=\"1459345667\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BP\" target=\"_blank\">BP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170328-bp-kuwait-petroleum-sign-framework-deal-on-oil-gas-petrochemicals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BP, Kuwait Petroleum sign framework deal on oil, gas, petrochemicals</a></h4><ul>     <li>BP (<a href=\"https://seekingalpha.com/symbol/BP\" title=\"BP p.l.c.\">BP</a> <font color=\"green\">+2.9%</font>) and Kuwait Petroleum <a href=\"http://www.bp.com/en/global/corporate/press/press-releases/bp-and-kuwait-petroleum-corporation-sign-agreement.html\" target=\"_blank\">sign a framework agreement</a> outlining cooperation on oil, gas and petrochemicals, and to explore possible opportunities for investment and cooperation in future ventures.</li>     <li>The agreement also includes plans to study opportunities for joint investment in future oil and gas exploration both inside Kuwait and globally, including potentially deploying BP's proprietary paraxylene technology as part of KPC's petrochemicals projects.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170328\" data-linked=\"BP, Kuwait Petroleum sign framework deal on oil, gas, petrochemicals\" data-tweet=\"$BP - BP, Kuwait Petroleum sign framework deal on oil, gas, petrochemicals https://seekingalpha.com/news/3170328-bp-kuwait-petroleum-sign-framework-deal-on-oil-gas-petrochemicals?source=tweet\" data-url=\"https://seekingalpha.com/news/3170328-bp-kuwait-petroleum-sign-framework-deal-on-oil-gas-petrochemicals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170322\" data-ts=\"1459344614\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170322-lululemon-jets-higher-conference-calls-tips-growth-drivers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lululemon jets higher as conference calls tips growth drivers</a></h4><ul> <li>Execs with Lululemon (NASDAQ:<a href=\"https://seekingalpha.com/symbol/LULU\" title=\"Lululemon Athletica Inc.\">LULU</a>) are saying all the right things early into the post-earnings conference call (Q&amp;A still coming).</li> <li>The company says it's placing a sharper focus on digital channels and international expansion. Those investments explain in part the 2016 guidance from the company that came in below expectations.</li> <li>Incremental markdowns helped Lululemon clear inventory in Q4. Looking ahead, management says it's confident inventory and sales level are now in sync. Q1 is expected to be the last period in which inventory overhang will have to be managed.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3170210-lululemon-athletica-beats-0_05-beats-revenue\" target=\"_blank\">Lululemon Athletica beats by $0.05, beats on revenue</a> (March 30)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3170232-lululemon-solid-q4-guidance-comes-behind-expectations\" target=\"_blank\">Lululemon solid in Q4, guidance comes in behind expectations</a> (March 30)</li> <li>LULU <font color=\"green\">+7.61%</font> premarket to $65.90 after being in negative territory earlier.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170322\" data-linked=\"Lululemon jets higher as conference calls tips growth drivers\" data-tweet=\"$LULU - Lululemon jets higher as conference calls tips growth drivers https://seekingalpha.com/news/3170322-lululemon-jets-higher-conference-calls-tips-growth-drivers?source=tweet\" data-url=\"https://seekingalpha.com/news/3170322-lululemon-jets-higher-conference-calls-tips-growth-drivers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170320\" data-ts=\"1459344524\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLMD\" target=\"_blank\">GLMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170320-galmed-pharmas-aramchol-shows-encouraging-anti-fibrotic-effect-in-preclinical-model-of-fatty\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Galmed Pharma&#39;s Aramchol shows encouraging anti-fibrotic effect in preclinical model of fatty liver disease; shares up 8% premarket</a></h4><ul>\n<li>Thinly traded nano cap Galmed Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GLMD\" title=\"Galmed Pharmaceuticals Ltd.\">GLMD</a>) is upÂ <font color=\"green\">8%</font>Â premarket, albeit on only 1,300 shares, in response to its <a href=\"https://www.sec.gov/Archives/edgar/data/1595353/000114420416091125/v435665_ex99-1.htm\" target=\"_blank\">announcement </a>of preclinical data on lead product candidate Aramchol that showed anti-fibrotic activity in a mouse model of fatty liver disease. The data showed statistically significant reductions in inflammation and liver fibrosis in work performed by a researcher in Spain.</li>\n<li>\n<a href=\"http://www.galmedpharma.com/products-2/aramchol/\" target=\"_blank\">Aramchol</a>, a conjugate of cholic acid and arachidic acid, is in Phase 2 development for the treatment of non-alcoholic steatohepatitis (NASH).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170320\" data-linked=\"Galmed Pharma&#39;s Aramchol shows encouraging anti-fibrotic effect in preclinical model of fatty liver disease; shares up 8% premarket\" data-tweet=\"$GLMD - Galmed Pharma&#39;s Aramchol shows encouraging anti-fibrotic effect in preclinical model of fatty liver disease; shares up 8% premarket https://seekingalpha.com/news/3170320-galmed-pharmas-aramchol-shows-encouraging-anti-fibrotic-effect-in-preclinical-model-of-fatty?source=tweet\" data-url=\"https://seekingalpha.com/news/3170320-galmed-pharmas-aramchol-shows-encouraging-anti-fibrotic-effect-in-preclinical-model-of-fatty\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170315\" data-ts=\"1459344095\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170315-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/ATNM' title='Actinium Pharmaceuticals, Inc.'>ATNM</a> <font color='green'>+12%</font>. SYMX <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='green'>+7%</font>. GALE <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/SONC' title='Sonic Corp.'>SONC</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/DNR' title='Denbury Resources Inc.'>DNR</a> <font color='green'>+5%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/VRNT' title='Verint Systems Inc.'>VRNT</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/OPK' title='OPKO Health, Inc.'>OPK</a> <font color='red'>-9%</font>. DV <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/SPKE' title='Spark Energy'>SPKE</a> <font color='red'>-7%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3170315\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$ACAD $ATNM $SES - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3170315-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3170315-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170313\" data-ts=\"1459343931\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCL\" target=\"_blank\">CCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170313-carnival-beats-0_07-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Carnival beats by $0.07, beats on revenue</a></h4><ul>\n<li>Carnival (NYSE:<a href=\"https://seekingalpha.com/symbol/CCL\" title=\"Carnival Corporation\">CCL</a>): FQ1 EPS of $0.39 <font color=\"green\">beats by $0.07</font>.</li>\n<li>Revenue of $3.65B (+3.4% Y/Y) <font color=\"green\">beats by $20M</font>.</li>\n<li>Shares <font color=\"green\">+3.75%</font> PM.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170313\" data-linked=\"Carnival beats by $0.07, beats on revenue\" data-tweet=\"$CCL - Carnival beats by $0.07, beats on revenue https://seekingalpha.com/news/3170313-carnival-beats-0_07-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3170313-carnival-beats-0_07-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170311\" data-ts=\"1459343610\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNF\" target=\"_blank\">UNF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170311-unifirst-lowered-guidance-for-fy2016-post-fq2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UniFirst lowered its guidance for FY2016 post FQ2 results</a></h4><ul>     <li>Unifirst (NYSE:<a href=\"https://seekingalpha.com/symbol/UNF\" title=\"UniFirst Corp.\">UNF</a>) reportsÂ Specialty Garments segment revenue rose 9.6% to $20.45M in FQ2.</li>     <li>Core Laundry revenue dropped 0.2% to $331.37M.</li>     <li>First Aid segment revenue increased 5.1% to $11.28M.</li>     <li>Gross profit rate declined 140 bps to 36.7%.</li>     <li>Operating margin rate -100 bps to 10.5%.</li>     <li>Segment earnings: Core Laundry operations: $36.13M (-11.7%);Â Specialty Garment: $1.15M (+364.1%);Â First Aid: $0.92M (-13.6%).</li>     <li>\n<b>FY2016 Guidance</b>:Â Revenues: $1.455B to $1.467B Diluted EPS: $5.45 to $5.65.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170311\" data-linked=\"UniFirst lowered its guidance for FY2016 post FQ2 results\" data-tweet=\"$UNF - UniFirst lowered its guidance for FY2016 post FQ2 results https://seekingalpha.com/news/3170311-unifirst-lowered-guidance-for-fy2016-post-fq2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3170311-unifirst-lowered-guidance-for-fy2016-post-fq2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170310\" data-ts=\"1459343535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XTNT\" target=\"_blank\">XTNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170310-fda-clears-xtant-medicals-new-laminoplasty-system-shares-up-16-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA clears Xtant Medical&#39;s new laminoplasty system; shares up 16% premarket</a></h4><ul>\n<li>Thinly traded nano cap <a href=\"http://xtantmedical.com/#products\" target=\"_blank\">Xtant Medical Holdings</a> (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/XTNT\" title=\"Xtant Medical Holdings, Inc.\">XTNT</a>) is upÂ <font color=\"green\">16%</font>Â premarket, albeit on turnover of only 2,200 shares, in response to its announcement that wholly owned subsidiary X-spine Systems has received FDA clearance of its Xspan Laminoplasty Fixation System.</li>\n<li>\n<a href=\"https://en.wikipedia.org/wiki/Laminoplasty\" target=\"_blank\">Laminoplasty </a>is a surgical procedure to relieve pressure on the spinal cord due to stenosis (narrowing of the canal). It involves cutting a portion of the vertebrae called the lamina to relieve the compression. The lamina is then restructured by a small plate that allows the spinal canal to increase in size without losing stability or movement in the vertebrae.</li>\n<li>The Xspan System is used in the lower cervical and upper thoracic spine (C3 - T3). According to the company, the global laminoplasty market is $110M. Commercial launch to key surgeons will commence in Q2 followed by a broader launch later in the year.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170310\" data-linked=\"FDA clears Xtant Medical&#39;s new laminoplasty system; shares up 16% premarket\" data-tweet=\"$XTNT - FDA clears Xtant Medical&#39;s new laminoplasty system; shares up 16% premarket https://seekingalpha.com/news/3170310-fda-clears-xtant-medicals-new-laminoplasty-system-shares-up-16-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3170310-fda-clears-xtant-medicals-new-laminoplasty-system-shares-up-16-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170300\" data-ts=\"1459342293\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LODE\" target=\"_blank\">LODE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170300-comstock-mining-launches-10m-share-offering-0_35\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comstock Mining launches 10M-share offering at $0.35</a></h4><ul>     <li>Comstock Mining (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/LODE\" title=\"Comstock Mining Inc\">LODE</a>) <font color=\"red\">-21.5%</font> premarket after pricing an underwritten public offering of 10M common shares at $0.35/share.</li>     <li>LODE says it plans to use the proceeds for exploration and development of the Lucerne and the Dayton mine projects, paying off its senior revolving credit facility and general corporate purposes.</li>     <li>Separately, LODE says it is partnering with American Mining and Tunneling for $5M in underground mine development, drilling and mining services, in exchange for issuance of up to 9M common shares at a value of at least $0.56/share.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170300\" data-linked=\"Comstock Mining launches 10M-share offering at $0.35\" data-tweet=\"$LODE - Comstock Mining launches 10M-share offering at $0.35 https://seekingalpha.com/news/3170300-comstock-mining-launches-10m-share-offering-0_35?source=tweet\" data-url=\"https://seekingalpha.com/news/3170300-comstock-mining-launches-10m-share-offering-0_35\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170295\" data-ts=\"1459341804\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICPT\" target=\"_blank\">ICPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170295-intercept-pharma-to-present-eight-abstracts-on-lead-product-candidate-european-liver-meeting\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intercept Pharma to present eight abstracts on lead product candidate at European Liver Meeting; shares up 3% premarket</a></h4><ul>\n<li>Intercept Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ICPT\" title=\"Intercept Pharmaceuticals\">ICPT</a>) has a full slate of abstract presentations on lead product candidate obeticholic acid (OCA)Â at the upcoming International Liver Congress 2016, the 51st Annual Meeting of the European Association for the Study of the Liver, in Barcelona Spain, April 13 - 17.</li>\n<li>The abstracts focus on the use of OCA in primary biliary cirrhosis (now called primary biliary cholangitis or PBC), and nonalcoholic steatohepatitis (NASH) and include new analyses of the Phase 3 POISE study and Phase 2 FLINT trial in NASH. Results from the Phase 2 CARE study in <a href=\"https://en.wikipedia.org/wiki/Biliary_atresia\" target=\"_blank\">biliary atresia </a>(bile duct is abnormally closed or absent) will also be presented.</li>\n<li>Shares are upÂ <font color=\"green\">3%</font>Â premarket but only on 1,162 shares.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170295\" data-linked=\"Intercept Pharma to present eight abstracts on lead product candidate at European Liver Meeting; shares up 3% premarket\" data-tweet=\"$ICPT - Intercept Pharma to present eight abstracts on lead product candidate at European Liver Meeting; shares up 3% premarket https://seekingalpha.com/news/3170295-intercept-pharma-to-present-eight-abstracts-on-lead-product-candidate-european-liver-meeting?source=tweet\" data-url=\"https://seekingalpha.com/news/3170295-intercept-pharma-to-present-eight-abstracts-on-lead-product-candidate-european-liver-meeting\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170294\" data-ts=\"1459341774\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIG\" target=\"_blank\">AIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170294-aig-gives-in-to-icahn-on-pay-upgraded-janney\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AIG gives in to Icahn on pay, upgraded at Janney</a></h4><ul>\n<li>Under pressure from Carl Icahn, <a href=\"https://seekingalpha.com/symbol/AIG\" title=\"American International Group Inc\">AIG</a> abandons the <a href=\"http://www.bloomberg.com/news/articles/2016-03-30/icahn-wins-on-aig-pay-as-credit-swaps-no-longer-tied-to-awards\" target=\"_blank\">use of CDS spreads</a> as a measure for long-term performance - and thus a measure for incentive pay - for its management team. The long-term incentive starting this year will likely be based on the insurer's total returns vs. peers, <a href=\"http://www.sec.gov/Archives/edgar/data/5272/000119312516521555/d125322ddef14a.htm\" target=\"_blank\">says the company</a>.</li>\n<li>Icahn earlier this year complained that tying executive pay to CDS would discourage management from wanting to split the company.</li>\n<li>In other news, <a href=\"http://www.streetinsider.com/Upgrades/Janney+Capital+Upgrades+American+International+Group+%28AIG%29+to+Buy/11457396.html\" target=\"_blank\">AIG is the recipient of </a>an upgrade to Buy from Janney Capital.</li>\n<li>SharesÂ <font color=\"green\">+1.15%</font>Â premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170294\" data-linked=\"AIG gives in to Icahn on pay, upgraded at Janney\" data-tweet=\"$AIG - AIG gives in to Icahn on pay, upgraded at Janney https://seekingalpha.com/news/3170294-aig-gives-in-to-icahn-on-pay-upgraded-janney?source=tweet\" data-url=\"https://seekingalpha.com/news/3170294-aig-gives-in-to-icahn-on-pay-upgraded-janney\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170287\" data-ts=\"1459341339\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STOR\" target=\"_blank\">STOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170287-store-capital-lower-oaktree-cashes-out\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">STORE Capital lower as Oaktree cashes out</a></h4><ul>\n<li>STORE Holding, a shareholder affiliated withÂ Oaktree Capital, sold all of its 33.34M shares in a public offering at a price of $25.25 each. STORE Capital (NYSE:<a href=\"https://seekingalpha.com/symbol/STOR\" title=\"STORE Capital\">STOR</a>) received no proceeds from the sale.</li>\n<li>The stock'sÂ <font color=\"red\">lower by 2.6%</font>Â premarket to $25.30.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170287\" data-linked=\"STORE Capital lower as Oaktree cashes out\" data-tweet=\"$STOR - STORE Capital lower as Oaktree cashes out https://seekingalpha.com/news/3170287-store-capital-lower-oaktree-cashes-out?source=tweet\" data-url=\"https://seekingalpha.com/news/3170287-store-capital-lower-oaktree-cashes-out\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170277\" data-ts=\"1459340541\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VICL\" target=\"_blank\">VICL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170277-vicals-antifungal-candidate-vlminus-2397-fast-trackd-for-invasive-aspergillosis-shares-up-16\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vical&#39;s antifungal candidate VL-2397 Fast Track&#39;d for invasive aspergillosis; shares up 16% premarket</a></h4><ul>\n<li>The FDA designates Vical's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/VICL\" title=\"Vical Incorporated\">VICL</a>) VL-2397 for Fast Track review for the treatment of invasive aspergillosis, an infection caused by inhaling the ubiquitous Aspergillus fungus.Â It is inconsequential in people with a normally functioning immune system, but can be dangerous in those with weakened immunity such as those undergoing hematopoietic stem cell transplantation, chemotherapy for leukemia or with AIDS.</li>\n<li>\n<a href=\"http://www.vical.com/products/ASP2397/default.aspx\" target=\"_blank\">VL-2397</a>, based on an isolate from a leaf litter fungusÂ AcremoniumÂ species collected in Malaysia, was initially developed by strategic partner Astellas Pharma (<a href=\"https://seekingalpha.com/symbol/alpmf\" target=\"_blank\">OTCPK:ALPMF</a>) (<a href=\"https://seekingalpha.com/symbol/alpmy\" target=\"_blank\">OTCPK:ALPMY</a>). A Phase 1 study was recently initiated.</li>\n<li>The FDA designated it a Qualified Infectious Disease Product in August 2015 and an Orphan Drug in January of this year.</li>\n<li>Shares are upÂ <font color=\"green\">16%</font>Â premarket on increased volume.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170277\" data-linked=\"Vical&#39;s antifungal candidate VL-2397 Fast Track&#39;d for invasive aspergillosis; shares up 16% premarket\" data-tweet=\"$VICL $BBI $ALPMF - Vical&#39;s antifungal candidate VL-2397 Fast Track&#39;d for invasive aspergillosis; shares up 16% premarket https://seekingalpha.com/news/3170277-vicals-antifungal-candidate-vlminus-2397-fast-trackd-for-invasive-aspergillosis-shares-up-16?source=tweet\" data-url=\"https://seekingalpha.com/news/3170277-vicals-antifungal-candidate-vlminus-2397-fast-trackd-for-invasive-aspergillosis-shares-up-16\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170274\" data-ts=\"1459340095\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLAY\" target=\"_blank\">PLAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170274-comps-impress-dave-busters-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comps impress at Dave &amp; Buster&#39;s again</a></h4><ul> <li>Dave &amp; Buster's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PLAY\" title=\"Dave &amp; Buster's Entertainment, Inc.\">PLAY</a>) trades lower, despite reporting strong Q4 numbers.</li> <li>Comparable-store sales growth of 6% was recorded even though the company ran up against last year's +10% mark. The two-year increase in comparable-store sales was 16.5%.</li> <li>Adjusted EBITDA as a percentage of revenue rose 340 bps to 28.3% as some costs were leveraged down.</li> <li>Guidance for FY16 from D&amp;B is for revenue of $967M to $987M vs. $975.97M consensus and adjusted EBITDA of $243M to $251M.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3170108-dave-and-busters-beats-0_10-beats-revenue\" target=\"_blank\">Dave &amp; Buster's beats by $0.10, beats on revenue</a> (March 29)</li> <li>PLAY <font color=\"red\">-1.63%</font> premarket to $38.60.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170274\" data-linked=\"Comps impress at Dave &amp; Buster&#39;s again\" data-tweet=\"$PLAY - Comps impress at Dave &amp; Buster&#39;s again https://seekingalpha.com/news/3170274-comps-impress-dave-busters-again?source=tweet\" data-url=\"https://seekingalpha.com/news/3170274-comps-impress-dave-busters-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170243\" data-ts=\"1459337449\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPK\" target=\"_blank\">OPK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170243-fda-rejects-opkos-rayaldee-nda-shares-down-9-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA rejects OPKO&#39;s RAYALDEE NDA; shares down 9% premarket</a></h4><ul>\n<li>OPKO Health (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/OPK\" title=\"OPKO Health, Inc.\">OPK</a>) is offÂ <font color=\"red\">9%</font>Â premarket on robust volume in response to its announcement that it received a Complete Response Letter (CRL) from the FDA regarding its New Drug Application (NDA) seeking approval of RAYALDEE (calcifediol) for the treatment of secondary hyperparathyroidism in patients with stage 3 or 4 chronic kidney disease and vitamin D insufficiency.</li>\n<li>The CRL cited deficiencies observed during an on-site inspection initiated at OPKO's third-party manufacturer on March 14. The observations were not specific to RAYALDEE manufacturing. The manufacturer has committed to respond promptly to the FDA's observations.</li>\n<li>OPKO will host a conference call this morning at 8:30 am ET to discuss the situation.</li>\n<li>\n<strong>Update</strong>: There were <a href=\"http://www.raps.org/Regulatory-Focus/News/2016/04/19/24797/Form-483-Details-Deficiencies-at-Catalent-Facility-Linked-to-Recent-CRL/\" target=\"_blank\">14 deficiencies</a> cited during an on-site FDA inspection of Catalent's (<a href=\"https://seekingalpha.com/symbol/CTLT\" title=\"Catalent\">CTLT</a> <font color=\"red\">-0.3%</font>) St. Petersburg, FL facility. The report, called a Form 483, noted that the company failed to inspect earlier batches of a gel for possible contamination after finding a contaminated gel receiver in its operation and it failed to follow its own standard operating procedure by waiting 11 days after the incident before the investigation was opened. Other deficiencies included improper documentation related to a malfunctioning refrigerator and failure to adequately respond to six complaints of blue spots on finished valporic acid capsules. Two other Catalent sites, Morrisville, NC and Beinheim, France, were cited for deficiencies last year.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170243\" data-linked=\"FDA rejects OPKO&#39;s RAYALDEE NDA; shares down 9% premarket\" data-tweet=\"$OPK $OPK $CTLT - FDA rejects OPKO&#39;s RAYALDEE NDA; shares down 9% premarket https://seekingalpha.com/news/3170243-fda-rejects-opkos-rayaldee-nda-shares-down-9-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3170243-fda-rejects-opkos-rayaldee-nda-shares-down-9-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>133&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170232\" data-ts=\"1459336330\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170232-lululemon-solid-in-q4-guidance-comes-in-behind-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lululemon solid in Q4, guidance comes in behind expectations</a></h4><ul> <li>Comparable-store sale rose 11% for Lululemon (NASDAQ:<a href=\"https://seekingalpha.com/symbol/LULU\" title=\"Lululemon Athletica Inc.\">LULU</a>) in Q4 on a constant dollar basis.</li> <li>Direct to consumer revenue was up 28% to $146.3M during the quarter to represent 21% of total sales.</li> <li>The company's gross profit rate fell back 120 bps Y/Y to 50.3%. The operating income rate was down 250 bps to 23.6%.</li> <li>Guidance for Q1 is set at an expectation for revenue of $483M to $488M vs. $485.2M consensus and EPS of $0.28 to $0.30 vs $0.37 consensus. For the full year, Lululemom sees $2.285M to $2.445M in sales vs. $2.33B consensus and EPS of $2.05 to $2.15 vs. $2.15 consensus.</li> <li>LUILU <font color=\"green\">+2.87%</font> premarket to $63.00. The conference call explanation from management on the EPS guidance could be key to the trading direction for Lululemon today.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3170210-lululemon-athletica-beats-0_05-beats-revenue\" target=\"_blank\">Lululemon Athletica beats by $0.05, beats on revenue</a> (March 30)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170232\" data-linked=\"Lululemon solid in Q4, guidance comes in behind expectations\" data-tweet=\"$LULU - Lululemon solid in Q4, guidance comes in behind expectations https://seekingalpha.com/news/3170232-lululemon-solid-in-q4-guidance-comes-in-behind-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3170232-lululemon-solid-in-q4-guidance-comes-in-behind-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170229\" data-ts=\"1459336120\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170229-world-lit-up-bright-green-post-yellen\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">World lit up bright green post-Yellen</a></h4><ul><li>The only major market not surging higher following Janet Yellen yesterday more or less taking another rate hike off the table for at least a couple of months is the Nikkei, which<font color='red'> fell 1.3%</font>&nbsp;overnight.</li><li>Shanghai&nbsp;<font color='green'>climbed 2.8%</font>&nbsp;and the Hang Seng&nbsp;<font color='green'>2.15%</font>. Europe's Stoxx 600 is&nbsp;<font color='green'>higher by 1.5%</font>.</li><li>U.S. stocks rallied yesterday afternoon post-Yellen, and futures are&nbsp;<font color='green'>higher by another 0.6%</font>&nbsp;this morning.</li><li>After a big decline in yield yesterday, the 10-year Treasury is up one basis point to 1.82%. Gold is flat and oil is<font color='green'> higher by 1.8%</font>&nbsp;to $38.97.</li></ul><div class=\"tiny-share-widget\" data-id=\"3170229\" data-linked=\"World lit up bright green post-Yellen\" data-tweet=\"World lit up bright green post-Yellen https://seekingalpha.com/news/3170229-world-lit-up-bright-green-post-yellen?source=tweet\" data-url=\"https://seekingalpha.com/news/3170229-world-lit-up-bright-green-post-yellen\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170217\" data-ts=\"1459333551\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAAS\" target=\"_blank\">CAAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170217-on-china-automitive-systems-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on China Automitive System&#39;s Q4</a></h4><ul>\n<li>China Automotive Systems (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CAAS\" title=\"China Automotive Systems, Inc.\">CAAS</a>)Â reports sales declined 11.2% in Q4 mainly due to decreased auto sales in a weak economic environment.</li>\n<li>Gross margin rate fell 90 bps to 16.8%Â as a result of weaker unit volume sales and a lower average selling price.</li>\n<li>Selling expense rate improved 10 bps to 3.3% for the period.</li>\n<li>Operating margin rate dropped 100 bps to 5.9%.</li>\n<li>The company expects revenue of $450M for FY2016.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170217\" data-linked=\"More on China Automitive System&#39;s Q4\" data-tweet=\"$CAAS - More on China Automitive System&#39;s Q4 https://seekingalpha.com/news/3170217-on-china-automitive-systems-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3170217-on-china-automitive-systems-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:25 AM </div></div></li>","count":47,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}